Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer

Cancer Medicine

Volumn 1, Issue 2, 2012, Pages 128-140

  Dayan, Dan ^a   Salo, Tuula ^b,c,d   Salo, Sirpa ^b   Nyberg, Pia ^b   Nurmenniemi, Sini ^b   Costea, Daniela Elena ^e   Vered, Marilena ^a,f  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UNIVERSITY OF BERGEN   (Norway)

^f SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cancer associated fibroblasts; Mobile tongue cancer; Molecular crosstalk; Myoma model; Protumorigenic inflammatory cells

Indexed keywords

B7 ANTIGEN; CD163 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER PROGNOSIS; CARCINOMA CELL; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; EXOSOME; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TONGUE CANCER; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

EID: 84873412613     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.24     Document Type: Article

References (34)

1. Ganly, I., S. Patel, and J. Shah. 2012. Early stage squamous cell cancer of the oral tongue - clinicopathologic features affecting outcome. Cancer 118:101-111.
2. Warnakulasuriya, S. 2009. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45:309-316.
3. Leemans, C. R., B. J. Braakhuis, and R. H. Brakenhoff. 2011. The molecular biology of head and neck cancer. Nat. Rev. Cancer 11:9-22.
4. Rethman, M. P., W. Carpenter, E. E. Cohen, et al. 2010. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinoma. J. Am. Dent. Assoc. 14:509-520.
5. Vered, M., D. Dayan, and T. Salo. 2011. The role of the tumour microenvironment in the biology of head and neck cancer: lessons from mobile tongue cancer. Nat. Rev. Cancer 11:382.
6. Vered, M., A. Dobriyan, D. Dayan, et al. 2010. Tumor-host histopathologic variables, stromal myofibroblasts and risk score are significantly associated with recurrent disease in tongue cancer. Cancer Sci. 101:274-280.
7. Bello, I. O., M. Vered, D. Dayan, et al. 2011. Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol. 47:33-38.
8. Vered, M., D. Dayan, R. Yahalom, et al. 2010. Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma. Int. J. Cancer 127:1356-1362.
9. Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancer-related inflammation. Nature 454:436-444.
10. Balkwill, F. R., and A. Mantovani. 2012. Cancer-related inflammation: common themes and therapeutic opportunities. Semin. Cancer Biol. 22:33-40.
11. Hanahan, D., and R. A. Weinberg. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
12. Erez, N., M. Truitt, P. Olson, S. T. Arron, and D. Hanahan. 2010. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 17:135-147.
13. Liu, M., J. Xu, and H. Deng. 2011. Tangled fibroblasts in tumor-stroma interactions. Int. J. Cancer 129:1795-1805.
14. Woolgar, J. A. 2006. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 42:229-239.
15. Brandwein-Gensler, M., M. S. Teixeira, C. M. Lewis, et al. 2005. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am. J. Surg. Pathol. 29:167-178.
16. Al-Qahtani, D., S. Anil, and R. Rajendran. 2011. Tumour infiltrating CD25+ FoxP3+ regulatory T cells (Tregs) relate to tumour grade and stromal inflammation in oral squamous cell carcinoma. J. Oral Pathol. Med. 40:636-642.
17. Badoua, C., S. Hans, J. Rodriguez, et al. 2006. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin. Cancer Res. 12:465-472.
18. Fujii, N., K. Shomori, T. Shiomi, et al. 2012. Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance. J. Oral Pathol. Med. 41:444-451.
19. Nurmenniemi, S., T. Sinikumpu, I. Alahuhta, et al. 2009. A novel organotypic model mimics the tumor microenvironment. Am. J. Pathol. 175:1281-1291.
20. Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl):S81-S96.
21. Kylmäniemi, M., A. Oikarinen, K. Oikarinen, and T. Salo. 1996. Effects of dexamethasone and cell proliferation on the expression of matrix metalloproteinases in human mucosal normal and malignant cells. J. Dent. Res. 75:919-926.
22. Webber, J., R. Steadman, M. D. Mason, Z. Tabi, and A. Clayton. 2010. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 70:9621-9630.
23. De Wever, O., and M. Mareel. 2002. Role of myofibroblasts at the invasion front. Biol. Chem. 383:55-67.
24. Lewis, A. M., S. Varghese, H. Xu, and H. R. Alexander. 2006. Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J. Transl. Med. 4:48.
25. Waugh, D. J., and C. Wilson. 2008. The interleukin-8 pathway in cancer. Clin. Cancer Res. 14:6735-6741.
26. Tung, J. W., M. D. Mrazek, Y. Yang, L. A. Herzenberg, and L. A. Herzenberg. 2006. Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse. Proc. Natl. Acad. Sci. USA 103:6293-6298.
27. Raposo, R. A., B. Thomas, G. Ridlova, and W. James. 2011. Proteomic-based identification of CD4-interacting proteins in human primary macrophages. PLoS One 6:e18690.
28. Aggarwal, B. B., S. Shishodia, S. K. Sandur, M. K. Pandey, and G. Sethi. 2006. Inflammation and cancer: how hot is the link? Biochem. Pharmacol. 72:1605-1621.
29. Tjomsland, V., A. Spangeus, J. Valila, et al. 2011. Expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts. Neoplasia 13:664-675.
30. Zhang, H. G., and W. E. Grizzle. 2011. Exosomes and cancer: a newly described pathway of immune suppression. Clin. Cancer Res. 17:959-964.
31. Willis, B. C., and Z. Borok. 2007. TGF-induced EMT: mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 293:L525-L534.
32. Balkwill, F. R. 2012. The chemokine system and cancer. J. Pathol. 226:148-157.
33. Cirri, P., and P. Chiarugi. 2012. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev. 31:195-208.
34. Jung, D. W., Z. M. Che, J. Kim, et al. 2010. Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Int. J. Cancer 127:332-344.